Related Experiment Video
Updated: Jul 29, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
[Fallot's tetralogy: current status of its treatment]
J I Herráiz Sarachaga1, R L Arciniegas, R Bermúdez-Cañete Fernández
1Servicio de Cardiología Pediátrica, Hospital Ramón y Cajal, Madrid.
Revista Espanola De Cardiologia
|February 1, 1996
Summary
This review covers current treatments for Tetralogy of Fallot, including pharmacological, interventional cardiology, and surgical options. It also addresses surgical outcomes, complications, and long-term follow-up for patients with this congenital heart defect.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Congenital Heart Disease
Background:
- Tetralogy of Fallot is a complex congenital heart defect requiring comprehensive management.
- Therapeutic strategies have evolved, necessitating a review of current options.
Purpose of the Study:
- To provide a comprehensive overview of all current therapeutic possibilities for Tetralogy of Fallot.
- To evaluate indications for surgical intervention and discuss post-surgical outcomes and complications.
Main Methods:
- Review of pharmacological and interventional cardiological procedures.
- Analysis of palliative and intracardiac corrective surgical procedures.
- Evaluation of surgical indications, sequelae, and long-term complications.
Main Results:
- Discussion of interventional cardiology techniques like balloon dilatation, coil embolization, pulmonary artery stenting, and ablation.
- Review of surgical approaches including palliative and corrective procedures, with assessment of primary vs. two-stage interventions.
- Description of early and late post-surgical sequelae, reoperation needs, and long-term complications such as arrhythmias and sudden death.
Conclusions:
- Current therapeutic strategies for Tetralogy of Fallot encompass a range of interventional cardiology and surgical options.
- Understanding post-surgical outcomes and long-term complications is crucial for optimal patient management and follow-up.
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...